% This is the RIPE Database query service.
% The objects are in RPSL format.
%
% The RIPE Database is subject to Terms and Conditions.
% See https://apps.db.ripe.net/docs/HTML-Terms-And-Conditions
% Information related to '195.216.225.0 - 195.216.225.255'
% Abuse contact for '195.216.225.0 - 195.216.225.255' is '[email protected]'
inetnum: 195.216.225.0 - 195.216.225.255
netname: SHRP-Net
country: US
org: ORG-SPL13-RIPE
admin-c: TB2998-RIPE
tech-c: TB2998-RIPE
status: ASSIGNED PI
mnt-by: RIPE-NCC-END-MNT
mnt-by: SHIRE-MNT
mnt-routes: SHIRE-MNT
mnt-domains: SHIRE-MNT
created: 2008-05-08T08:43:28Z
last-modified: 2016-04-14T10:14:14Z
source: RIPE
organisation: ORG-SPL13-RIPE
org-name: Takeda Pharmaceuticals U.S.A., Inc.
country: US
org-type: LIR
address: 95 Hayden Avenue
address: MA 02421
address: Lexington
address: UNITED STATES
phone: +14845958237
phone: +1-630-835-8017
e-mail: [email protected]
abuse-c: AC31348-RIPE
mnt-by: SHIRE-MNT
mnt-ref: SHIRE-MNT
mnt-ref: RIPE-NCC-HM-MNT
mnt-by: RIPE-NCC-HM-MNT
created: 2013-12-11T09:35:52Z
last-modified: 2021-02-05T08:22:35Z
source: RIPE
person: Tim Brock
address: Shire Pharmaceutical Limited
address: 725 Chesterbrook Boulevard
address: Wayne
address: Pennsylvania
address: PA 19087-5637
address: USA
phone: +44 1256 894 262
e-mail: [email protected]
nic-hdl: TB2998-RIPE
mnt-by: CIP-MNT
created: 2008-04-25T14:31:47Z
last-modified: 2008-09-04T15:15:51Z
source: RIPE